Literature DB >> 33765216

Bi-direction effects between microbiome and MiRNAs in carcinogenesis.

Qinglin Wang1,2, Hanlin Ding1,2, Gaochao Dong1,2, Lin Xu3,4, Feng Jiang5,6, Qixing Mao7,8.   

Abstract

There is evidence from numerous studies that dysbiosis of the microbiome provokes various immune-mediated diseases, obesity, diabetes, and cancers by regulating metabolites, host genetics, environmental elements, and stress. Such reports are yet to define an accurate regulatory network for host-gut microbiome communication. miRNAs have recently emerged as crucial mediators of this communication, as portrayed by their interaction with the host microbiome. This mini-review summarizes the bi-direction effects between miRNA and microbiome and elucidates their role in carcinogenesis. An in-depth understanding of the association of miRNA with host-microbiome could be valuable to improve cancer remission, diagnosis, and treatment, and may help to potential tumor markers.

Entities:  

Keywords:  Bi-direction; Carcinogenesis; Microbiome; miRNAs

Mesh:

Substances:

Year:  2021        PMID: 33765216     DOI: 10.1007/s00432-021-03567-w

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  46 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

Authors:  Esther E Creemers; Anke J Tijsen; Yigal M Pinto
Journal:  Circ Res       Date:  2012-02-03       Impact factor: 17.367

Review 3.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

Review 4.  Role of the microbiota in hematologic malignancies.

Authors:  A Allegra; V Innao; A G Allegra; R Ettari; M Pugliese; N Pulvirenti; C Musolino
Journal:  Neth J Med       Date:  2019-02       Impact factor: 1.422

Review 5.  The role of the microbiome in cancer development and therapy.

Authors:  Aadra P Bhatt; Matthew R Redinbo; Scott J Bultman
Journal:  CA Cancer J Clin       Date:  2017-05-08       Impact factor: 508.702

Review 6.  The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease.

Authors:  Robert P Dickson; Gary B Huffnagle
Journal:  PLoS Pathog       Date:  2015-07-09       Impact factor: 6.823

7.  Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment.

Authors:  Michael B Burns; Emmanuel Montassier; Juan Abrahante; Sambhawa Priya; David E Niccum; Alexander Khoruts; Timothy K Starr; Dan Knights; Ran Blekhman
Journal:  PLoS Genet       Date:  2018-06-20       Impact factor: 5.917

8.  The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.

Authors:  Berk Aykut; Smruti Pushalkar; Ruonan Chen; Qianhao Li; Raquel Abengozar; Jacqueline I Kim; Sorin A Shadaloey; Dongling Wu; Pamela Preiss; Narendra Verma; Yuqi Guo; Anjana Saxena; Mridula Vardhan; Brian Diskin; Wei Wang; Joshua Leinwand; Emma Kurz; Juan A Kochen Rossi; Mautin Hundeyin; Constantinos Zambrinis; Xin Li; Deepak Saxena; George Miller
Journal:  Nature       Date:  2019-10-02       Impact factor: 49.962

9.  Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.

Authors:  Tomer Cooks; Ioannis S Pateras; Lisa M Jenkins; Keval M Patel; Ana I Robles; James Morris; Tim Forshew; Ettore Appella; Vassilis G Gorgoulis; Curtis C Harris
Journal:  Nat Commun       Date:  2018-02-22       Impact factor: 14.919

10.  Mucosal microbiome dysbiosis in gastric carcinogenesis.

Authors:  Olabisi Oluwabukola Coker; Zhenwei Dai; Yongzhan Nie; Guijun Zhao; Lei Cao; Geicho Nakatsu; William Kk Wu; Sunny Hei Wong; Zigui Chen; Joseph J Y Sung; Jun Yu
Journal:  Gut       Date:  2017-08-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.